HOXD3 and hepatocellular carcinoma: To identify the core activating region, a dual-luciferase reporter assay was performed by co-transfecting the reporter fragment containing the binding site (−503 to −304) with either HOXD3-Ctrl or HOXD3 into HCC cells.